Janssen
Reports: Drug manufacturers and middlemen both responsible for rising consumer costs
The world of prescription drug pricing can be bewildering — intentionally so, some critics of the industry claim. Whether that’s true or not, several reports this year show that the supply chain’s alchemy of list prices, rebates and net prices hurts consumers. And a U.S. Senate report says drugmakers and middlemen share the blame. The […]
Drugmaker on rising prices: Don’t look at us
A subsidiary of a leading U.S. drugmaker is reporting that the net cost of its products has been falling. If that’s true, it would appear that drug middlemen and insurers are driving increases in the overall cost of medicine and in consumers’ out-of-pocket costs at the counter. The report, by Johnson & Johnson subsidiary Janssen […]